Role of SIRT6 in the pancreatic beta cell aging

项目摘要 在衰老过程中，胰岛β细胞的胰岛素分泌能力下降，而这 与65岁以上人群相比，65岁以上人群糖尿病患病率增加近3倍 普通人口。Sirtuin 6(SIRT6)是一种组蛋白脱乙酰酶，被认为是一种长寿因素。 在初步研究中，我们已经证明了SIRT6是维持正常的β细胞所必需的 在衰老过程中，SIRT6在β细胞中下调。因此，我们假设SIRT6 在保护胰岛β细胞免受衰老相关细胞损伤中起重要作用 损坏。在本研究中，我们将研究SIRT6在细胞周期调控中的作用和机制。 胰岛β细胞老化。我们期望这个项目的发现将推动我们的 了解胰岛β细胞衰老的基本过程并提供潜力 年龄相关性糖尿病防治发展的新靶点。

Project Summary During aging, pancreatic beta cells undergo a decline in insulin secretion capacity, and this contributes to nearly 3-fold high diabetes prevalence in people aged over 65 years compared to the general population. Sirtuin 6 (SIRT6), a histone deacetylase, has been suggested to be a longevity factor. In the preliminary study, we have demonstrated that SIRT6 is required to maintain normal beta cell function and SIRT6 is downregulated in the beta cells during aging. Therefore, we hypothesize that SIRT6 plays an important role in the protection of pancreatic beta cells against aging-associated cellular damage. In this application, we will investigate the SIRT6 function and mechanism in the regulation of pancreatic beta cell aging. It is our expectation that the findings from this project will advance our understanding of the fundamental process of the aging of pancreatic beta cells and provide potential novel targets for the development of prevention and treatment of the age-related diabetes.